<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31722">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01834118</url>
  </required_header>
  <id_info>
    <org_study_id>CVC-001</org_study_id>
    <nct_id>NCT01834118</nct_id>
  </id_info>
  <brief_title>Reintervention-study After Previous Renal Denervation in Non-responding Patients With Severe Hypertension</brief_title>
  <acronym>RETREAT</acronym>
  <official_title>Reintervention After Previous Renal Denervation in Non-responding Patients With Severe Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiovascular Center Frankfurt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardiovascular Center Frankfurt</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of repeated renal denervation in
      non-responding patients with severe hypertension. Therefore ultrasound technique will be
      used.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Renal Denervation is a CE-certified opportunity for treating patients with
      therapy-refractory hypertension. In some patients it doesn't show a significant lowering of
      the blood pressure, so a repeated renal denervation is an option.

      In this study repeated renal denervation will be performed with the Recor Paradise
      Ultrasound Catheter.

      For the study no specific procedures are required which would exceed the standard renal
      denervation procedure with the CE-certified Recor Paradise Ultrasound Catheter System.

      There are no additional risks for the patient in consequence of participating in the study
      or the follow up procedures.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Office Blood pressure measurement</measure>
    <time_frame>up to1 year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hypertension, Resistant to Conventional Therapy</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Renal Denervation</intervention_name>
    <description>Sympathetic nerve ablation via transcatheter renal denervation</description>
    <other_name>Renal sympathetic nerve ablation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with treatment-resistant hypertension, who already underwent renal denervation
        with no therapeutic avail.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individual is ≥18 years old

          -  Individual received renal denervation ≥12 months prior to study participation to no
             therapeutical avail and is scheduled for reintervention.

          -  Systolic Office based blood pressure ≥140mmHg

          -  Individual receives 3 or more antihypertensive drugs including one diuretic

          -  Individual is willing to provide written informed consent to participate in this
             study

        Exclusion Criteria:

          -  Individual has hypertension secondary to an identifiable and treatable cause

          -  Individual has any serious medical condition which in the opinion of the investigator
             may adversely affect the participation.

          -  Individual is pregnant, nursing or planning to be pregnant

          -  Renal artery abnormalities which may affect the procedure
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Horst Sievert, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiovascular Center Frankfurt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roger Eckhardt</last_name>
    <phone>0049 69 97947653</phone>
    <email>r.eckhardt@cvcfrankfurt.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>CardioVascular Center Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roger Eckhardt</last_name>
      <phone>0049 69 97947653</phone>
      <email>r.eckhardt@cvcfrankfurt.de</email>
    </contact>
    <investigator>
      <last_name>Horst Sievert, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 10, 2013</lastchanged_date>
  <firstreceived_date>April 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cardiovascular Center Frankfurt</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Horst Sievert</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
